|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.952
|
Human Mouse |
|
|
carnitine transmembrane transport
|
GO:1902603 |
3 |
0.921
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.916
|
Human Mouse |
|
|
urate transport
|
GO:0015747 |
1 |
0.913
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.867
|
Human Mouse |
|
|
histamine uptake
|
GO:0051615 |
1 |
0.838
|
|
|
|
carnitine transport
|
GO:0015879 |
3 |
0.807
|
|
|
|
amino acid betaine transport
|
GO:0015838 |
3 |
0.595
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.392
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.377
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.365
|
Human Mouse |
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.325
|
Human Mouse |
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.253
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.252
|
Human Mouse |
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.244
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.218
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.209
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.205
|
Human Mouse |
|
|
monoamine transport
|
GO:0015844 |
33 |
0.204
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.188
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.185
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.183
|
Human |
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.176
|
|
|
|
carnitine metabolic process
|
GO:0009437 |
7 |
0.175
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.174
|
Human Mouse |
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.170
|
Human |
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.166
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
29 |
0.163
|
|
|
|
modified amino acid transport
|
GO:0072337 |
5 |
0.160
|
|
|
|
amino acid betaine metabolic process
|
GO:0006577 |
7 |
0.157
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.157
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.154
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.153
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.140
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.140
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.140
|
Human Mouse |
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.140
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.137
|
|
|
|
inorganic anion transport
|
GO:0015698 |
43 |
0.129
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.128
|
|
|
|
chloride transport
|
GO:0006821 |
32 |
0.125
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.122
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.121
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.120
|
|
|
|
l alpha amino acid transmembrane transport
|
GO:1902475 |
23 |
0.120
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.108
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.104
|
|
|
|
histamine transport
|
GO:0051608 |
2 |
0.104
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.103
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.101
|
|
|
|
chloride transmembrane transport
|
GO:1902476 |
24 |
0.100
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.098
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.098
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.096
|
Human Mouse |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.094
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.094
|
|
|
|
memory
|
GO:0007613 |
58 |
0.091
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.091
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.090
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.089
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.087
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.085
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.085
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.084
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.082
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.080
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.079
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.079
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.078
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.077
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.077
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.076
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.076
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.074
|
|
|
|
neutral amino acid transport
|
GO:0015804 |
13 |
0.071
|
Human Mouse |
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.071
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.070
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.070
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.070
|
|
|
|
methionine transport
|
GO:0015821 |
1 |
0.068
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.067
|
|
|
|
sulfur compound transport
|
GO:0072348 |
9 |
0.066
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.065
|
|
|
|
regulation of appetite
|
GO:0032098 |
12 |
0.064
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.064
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.063
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.062
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.062
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.062
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.062
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.062
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.061
|
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.061
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.060
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.060
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.060
|
|
|
|
regulation of serotonin secretion
|
GO:0014062 |
3 |
0.059
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.059
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.059
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.058
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.058
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.058
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.058
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.058
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.058
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.057
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.057
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.056
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.055
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.055
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.054
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.054
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.054
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.053
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.052
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.052
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.052
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.050
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.050
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.049
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.049
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.049
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.047
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.047
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.047
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.047
|
|
|
|
negative regulation of serotonin secretion
|
GO:0014063 |
2 |
0.047
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.047
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.046
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.046
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.046
|
|
|
|
positive regulation of t cell extravasation
|
GO:2000409 |
2 |
0.046
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.046
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.046
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.046
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.046
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.045
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.045
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.045
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.045
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.044
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.044
|
|
|
|
histamine induced gastric acid secretion
|
GO:0001697 |
1 |
0.044
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.044
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.044
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.044
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.043
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.043
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.043
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.043
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.043
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.042
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.042
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.042
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.042
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.042
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.041
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.041
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.041
|
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.040
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.040
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.040
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.040
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.040
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.040
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.040
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.040
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.040
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.039
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.039
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.039
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.039
|
|
|
|
protein kinase c activating g protein coupled receptor signaling pathway
|
GO:0007205 |
4 |
0.039
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.038
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.038
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.038
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.038
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.037
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.037
|
|
|
|
regulation of inward rectifier potassium channel activity
|
GO:1901979 |
1 |
0.037
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.037
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.036
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.036
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.036
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.036
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.036
|
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.036
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.036
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.035
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.035
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.035
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.035
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.035
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.035
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.034
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.034
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.034
|
|
|
|
dopamine metabolic process
|
GO:0042417 |
23 |
0.034
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.034
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.034
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.034
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.032
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.032
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.032
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.032
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.032
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.031
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.031
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.031
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.031
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.031
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.031
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.031
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.031
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.030
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.030
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.030
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.030
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.030
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.030
|
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.029
|
|
|
|
d amino acid transport
|
GO:0042940 |
1 |
0.029
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.029
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.029
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.029
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.029
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.029
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.029
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.028
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.028
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.028
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.028
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.028
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.028
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.028
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
3 |
0.028
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.028
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.028
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.028
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.028
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.028
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.027
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.027
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.027
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.027
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.027
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.027
|
|
|
|
positive regulation of vasoconstriction
|
GO:0045907 |
4 |
0.027
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.027
|
|
|
|
alanine transport
|
GO:0032328 |
4 |
0.027
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.027
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.027
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.027
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.027
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.027
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.027
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.026
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.026
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.026
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.026
|
|
|
|
negative regulation of eosinophil degranulation
|
GO:0043310 |
1 |
0.026
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.026
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.026
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.026
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.025
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.025
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.025
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.025
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.025
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.025
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.025
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
49 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.025
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.025
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.025
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.025
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.024
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.024
|
|
|
|
receptor mediated endocytosis of low density lipoprotein particle involved in cholesterol transport
|
GO:0090118 |
1 |
0.024
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.024
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.024
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.024
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.024
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.024
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.024
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.024
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
3 |
0.024
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.024
|
|
|
|
regulation of urine volume
|
GO:0035809 |
6 |
0.024
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.024
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.024
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.024
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.023
|
|
|
|
sensitization
|
GO:0046960 |
2 |
0.023
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.023
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.023
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.023
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.023
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.022
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.022
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.022
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.022
|
|
|
|
negative regulation of wnt signaling pathway involved in heart development
|
GO:0003308 |
4 |
0.022
|
|
|
|
positive regulation of glycolytic process
|
GO:0045821 |
4 |
0.022
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.022
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.022
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.021
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.021
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.021
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.021
|
|
|
|
transepithelial chloride transport
|
GO:0030321 |
4 |
0.021
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.021
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.021
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.021
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.021
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.021
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.021
|
|
|
|
detection of mechanical stimulus involved in sensory perception of pain
|
GO:0050966 |
4 |
0.021
|
|
|
|
urate metabolic process
|
GO:0046415 |
2 |
0.021
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.021
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.021
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.020
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure by norepinephrine epinephrine
|
GO:0001993 |
8 |
0.020
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
positive regulation of t cell receptor signaling pathway
|
GO:0050862 |
4 |
0.020
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.020
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.020
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.020
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.020
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.020
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
habituation
|
GO:0046959 |
3 |
0.020
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.020
|
|
|
|
negative regulation of cholesterol efflux
|
GO:0090370 |
4 |
0.020
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
3 |
0.020
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.020
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.020
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.020
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.020
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.019
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.019
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.019
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.019
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.019
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.019
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.019
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.019
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.019
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.019
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.019
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.019
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.019
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.019
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.019
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.019
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.019
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.019
|
|
|
|
phosphate ion transport
|
GO:0006817 |
3 |
0.018
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.018
|
|
|
|
neurotransmitter uptake
|
GO:0001504 |
14 |
0.018
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.018
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.018
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.018
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.018
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.018
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.018
|
|
|
|
t helper 17 cell chemotaxis
|
GO:0035705 |
1 |
0.018
|
|
|
|
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation
|
GO:2000526 |
1 |
0.018
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.018
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.018
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.018
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.017
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.017
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.017
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.017
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.017
|
|
|
|
cellular response to temperature stimulus
|
GO:0071502 |
2 |
0.017
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.017
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.017
|
|
|
|
hexose transmembrane transport
|
GO:0035428 |
7 |
0.017
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.017
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.017
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.017
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.017
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.017
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
1 |
0.017
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.017
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.017
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.017
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
36 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.017
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.016
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.016
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.016
|
|
|
|
cellular response to hexose stimulus
|
GO:0071331 |
47 |
0.016
|
|
|
|
negative regulation of blood pressure
|
GO:0045776 |
22 |
0.016
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.016
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.016
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.016
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.016
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.016
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.016
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.016
|
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.016
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.016
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.016
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.016
|
|
|
|
response to corticosterone
|
GO:0051412 |
1 |
0.016
|
|
|
|
activation of phospholipase c activity
|
GO:0007202 |
2 |
0.016
|
|
|
|
azole transport
|
GO:0045117 |
6 |
0.016
|
|
|
|
positive regulation of cytosolic calcium ion concentration involved in phospholipase c activating g protein coupled signaling pathway
|
GO:0051482 |
4 |
0.016
|
|
|
|
d serine transport
|
GO:0042942 |
1 |
0.016
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.016
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.015
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.015
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.015
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.015
|
|
|
|
t cell extravasation
|
GO:0072683 |
4 |
0.015
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.015
|
|
|
|
negative regulation of macrophage apoptotic process
|
GO:2000110 |
3 |
0.015
|
|
|
|
positive regulation of immunological synapse formation
|
GO:2000522 |
1 |
0.015
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.015
|
|
|
|
learning
|
GO:0007612 |
98 |
0.015
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.015
|
|
|
|
dopamine receptor signaling pathway
|
GO:0007212 |
16 |
0.015
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.015
|
|
|
|
vasodilation
|
GO:0042311 |
28 |
0.015
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.015
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.015
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.015
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.015
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.015
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.015
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.015
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.015
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.015
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.015
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.015
|
|
|
|
response to folic acid
|
GO:0051593 |
2 |
0.015
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.015
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.015
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.014
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.014
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.014
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.014
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.014
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.014
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.014
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.014
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.014
|
|
|
|
cellular response to prostaglandin d stimulus
|
GO:0071799 |
1 |
0.014
|
|
